
Topical Diclofenac 3% Gel for Actinic Keratosis May Induce Terminal Hair in Male Androgenetic Alopecia: A Report of Three Cases
Recently topical 3% diclofenac is commonly used to treat actinic keratosis (AK). It is proposed that it may also have a potential effect on hair growth....

The researchers focused on what they thought was due to an anti-inflammatory effect. Problem with that is most/all anti-inflammatories CAUSE hair loss. The hair follicle NEEDS INFLAMMATION to begin anagen. Problem is and my pet hypothesis is that: surrounding senescent cells create an inflammatory environment to the surrounding cells(see the hair transplant video and think of what I'm saying).
The hair follicle is surrounded by "noise" of senescent inflammation then and do not respond well to normal hair inflammation signals. Too much senescence inflammation makes it difficult to pick up any normal inflammation which would start up anagen again.
The conclusion can be one and only one and that is diclofenac was acting like a senolytic agent clearing out actinic keratoses(which are composed of senescent cells) but also even deeper down into the hair follicle probably wiping out senescent dermal papilla.
There is NO WAY that the guy could have been still regrowing hair __4 YEARS_ after the treatment ended if we were just blocking COX-2 pathways..
Diclofenac is terribly damaging to the mitochondria and that is why it was used in the first place.

Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced liver injury (DILI) - PubMed
Diclofenac is a widely prescribed NSAID, which by itself and its reactive metabolites (Phase-I and Phase-II) may be involved in serious idiosyncratic hepatotoxicity. Mitochondrial injury is one of the mechanisms of drug induced liver injury (DILI). In the present work, an investigation of the...

AI Overview
Learn more
Actinic keratosis (AK) is a precancerous skin condition that can be treated with senolytic drugs. Senolytic drugs are currently being tested in clinical trials for several age-related diseases and some cancers.
Last edited: